Metabolic characterization of childhood brain tumors: Comparison of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography

Cancer

Volumn 95, Issue 6, 2002, Pages 1376-1386

  Utriainen, Meri ^a,e   Metsähonkala, Liisa ^a   Salmi, Toivo T ^a   Utriainen, Tapio ^b   Kalimo, Hannu ^a   Pihko, Helena ^b   Mäkipernaa, Anne ^c   Harila Saari, Arja ^d   Jyrkkiö, Sirkku ^a   Laine, Jukka ^a   Någren, Kjell ^a   Minn, Heikki ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d UNIVERSITY OF OULU   (Finland)

^e Department of Oncology ^*  (Finland)

Author keywords

2 18F fluoro 2 deoxy D glucose; Brain tumor; Child; L methyl 11C methionine; Positron emission tomography; Tumor metabolism

Indexed keywords

FLUORODEOXYGLUCOSE F 18; KI 67 ANTIGEN; METHIONINE C 11;

ADOLESCENT; APOPTOSIS; ARTICLE; BOLUS INJECTION; BRAIN METABOLISM; BRAIN TOMOGRAPHY; BRAIN TUMOR; CANCER GRADING; CELL DENSITY; CELL PROLIFERATION; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DRUG UPTAKE; FEMALE; FOLLOW UP; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; INFANT; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL;

ADOLESCENT; AGE FACTORS; APOPTOSIS; BRAIN NEOPLASMS; CARBON RADIOISOTOPES; CHILD; CHILD, PRESCHOOL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INFANT; MALE; METHIONINE; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0037105411     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10798     Document Type: Article

References (54)

1. Brain tumors in children
2. Clinical application of PET for the evaluation of brain tumors
3. Prediction of brain tumor therapy response by PET
4. 18F) fluorodeoxyglucose and positron emission tomography
5. Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: A PET study
6. Positron emission tomography in patients with glioma
7. Prediction of survival in glioma patients by means of positron emission tomography
8. 18F)fluorodeoxyglucose positron emission tomography
9. 11C-methionine for diagnosis of recurrent brain tumor and radiation injury
10. 11C)L-methionine uptake in gliomas
11. Discrepancies in brain tumor extent as shown by computed tomography and positron emission tomography using [68Ga]EDTA, [11C]glucose, and [11C]methionine
12. 11C-methionine and positron emission tomography
13. Positron emission tomography with 11C-methionine and computed tomography of intracranial tumours compared with histopathological examination of multiple biopsies
14. 18F-fluorodeoxyglucose in prolactinomas in relation to bromocryptine treatment
15. 11C-L-methylmethionine
16. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxy-glucose and/or carbon-11-methionine
17. 11C-methionine
18. FGD-PET in pediatric posterior fossa brain tumors
19. In vivo metabolism of childhood posterior fossa tumors and primitive neuroectodermal tumors before and after treatment
20. Two-phase [11C]L-methionine PET in childhood brain tumors
21. Physical performance of the latest generation of commercial positron scanner
22. Performance characteristics of a whole-body PET scanner
23. Efficient stereospecific synthesis of no-carrier-added 2-(18F)-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution
24. 11C)methionine
25. 11C] methionine
26. 11C)-methionine
27. Prediction of survival with fluorine-18-fluorodeoxyglucose and PET in head and neck cancer
28. Expression of tissue isotope distribution
29. Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples
30. Comparison of three quantitation methods for PCNA immunostaining: Applicability and relation to survival in 83 astrocytic neoplasms
31. Effects of therapeutic ultrasound on the regeneration of skeletal myofibers after experimental muscle injury
32. Lipopolysaccharide induced apoptosis of rat pancreatic acinar cells
33. 18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool
34. New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose
35. 11C-methionine PET for differential diagnosis of low-grade gliomas
36. The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas
37. Neuroimaging of juvenile pilocytic astrocytomas: An enigma
38. Abnormal cerebral glucose metabolism in long-term survivors of childhood acute lymphocytic leukemia
39. Reduced cerebral glucose metabolism and increased brain capillary permeability following high-dose methotrexate chemotherapy: A positron emission tomographic study
40. Glucose metabolic changes in nontumoral brain tissue of patients with brain tumor following radiotherapy: A preliminary study
41. Acute high-dose methotrexate neurotoxicity in the rat
42. Progressive perturbations in cerebral energy metabolism after experimental whole-brain radiation in the therapeutic range
43. Can the standardized uptake value characterize primary brain tumor on FDG-PET?
44. Cerebral blood flow and glucose metabolism in long-term survivors of childhood acute lymphoblastic leukaemia
45. Decreased cerebral glucose metabolism in patients with brain tumors: An effect of corticosteroids
46. Dexamethasone treatment and plasma glucose levels: Relevance for fluorine-18-fluorodeoxyglucose uptake measurements in gliomas
47. The effect of carbamazepine on cerebral glucose metabolism
48. Effect of phenytoin on human cerebral glucose metabolism
49. Effect of valproate on cerebral metabolism and blood flow: An 18F-2-deoxyglucose and 15O water positron emission tomography study
50. Cerebral metabolism during propofol anesthesia in humans studied with positron emission tomography
51. Positron emission tomography study of human brain functional development
52. L-methionine uptake by human cerebral cortex: Maturation from infancy to old age
53. Correlation of glucose consumption and tumor cell density in astrocytomas. A stereotactic PET study